Biotech · Private company
Actinogen Medical
Track this companyFree. Adds Actinogen Medical to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- XanamemPhase 3 · Dementia ModerateClinicalTrials.gov · fetched Nov 12, 2026
- Xanamem™Phase 2 · Dementia, Alzheimer TypeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Effect of 10 mg Xanamem on Dementia Due to Alzheimer's DiseasePHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Apr 12, 2024ClinicalTrials.gov NCT06125951 · fetched Nov 12, 2026
- A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)PHASE2 · COMPLETED · started Mar 23, 2017ClinicalTrials.gov NCT02727699 · fetched Nov 12, 2026